Corbus Pharmaceuticals Holdings, Inc. (CRBP)
10.10
-0.27
(-2.60%)
USD |
NASDAQ |
Dec 09, 16:00
10.28
+0.18
(+1.78%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Total Liabilities (Quarterly): 17.37M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | 11.57M |
| Perspective Therapeutics, Inc. | 52.61M |
| Protalix Biotherapeutics, Inc. | 29.36M |
| Electromed, Inc. | 8.869M |
| Armata Pharmaceuticals, Inc. | 185.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 109.51M |
| Shareholders Equity (Quarterly) | 92.15M |
| Debt to Equity Ratio | 0.0222 |
| Current Ratio | 6.306 |
| Net Debt Paydown Yield | 1.61% |